Feedback
AUROPHARMA 
Reputation: 642,681 • Aug 7, 2023 3:43 PM
Aurobindo Pharma shares hit 52-week high on US FDA approval for drug to treat infection
The company's board of directors will meet on August 12, 2023, to consider and approve the standalone and consolidated unaudited financial results of the company for the first quarter ended June 30, 2023.
Moneycontrol
Vote
Comment
Share
NSE:AUROPHARMA price when posted: 855.15